PerkinElmer's Prenatal Screening Subsidiary Moves to Larger Facility on Long Island | GenomeWeb
NEW YORK (GenomeWeb News) – PerkinElmer said on Tuesday that its prenatal screening subsidiary NTD Laboratories has relocated to a new 22,000-square-foot facility in Melville, NY.
 
PerkinElmer said that NTD moved to the new facility from its previous location in Huntington Station, NY, to meet increasing demand for prenatal screening, including tests for Down syndrome, trisomy 18/13, and open neural tube defects, among others.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.